News

Humabs BioMed opens new research laboratory

Humabs BioMed has inaugurated a new research laboratory in Bellinzona. Two years ago, the Ticino-based biotech company was taken over by US corporation Vir Biotechnology, which is now investing in Humabs BioMed’s home town with the new laboratory.

Belova59
Generic Image: Belova59/Pixabay

Humabs BioMed has opened a new research laboratory in Bellinzona. According to a press release, the new construction covers an area of 500 square meters in the Business Center in Bellinzona. The laboratory also features office space of the same surface area. The new location will have space for more than 50 employees to work.

Humabs BioMed conducts research into active agents to treat infectious diseases and has developed, among other things, an antibody to combat the Ebola virus. The firm was hived off from the Institute for Research in Biomedicine in Bellinzona in 2004. In 2017, it was taken over by the US corporation Vir Biotechnology. Following the takeover, Vir Biotechnology not only decided to retain the headquarters of Humabs BioMed in Ticino, but also invested heavily in the new location. This is according to Filippo Riva, General Director of Humabs BioMed, who also comments: “We are proud to have consolidated our presence in Bellinzona, a town that over the years has strengthened its position as an international center of scientific research”.

Moreover, Riva claims that the new location should help strengthen research lines and accelerate development.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

Download
Recommend us
How should we contact you?

Premium Partner

Strategic partners

Institutional partner

Official program